AKT1 and acute myeloid leukemia: found that curcumin significantly improved the growth‐inhibitory effect of daunorubicin in primary CD34+/CD38− AML cells, largely through the downregulation of osteopontin (OPN), a gene associated with leukemic stem cell survival and chemoresistance via the AKT/mTOR pathway (Ahmed et al. 2020).